JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Antibodies: Precision Guided to the Cell Surface

Monoclonal antibodies are the workhorse biologic. Here's what makes them so selective, why they can't go inside cells, and how engineering — bispecifics, ADCs — extends their reach.

Why antibodies are so exquisitely selective

A monoclonal antibody is a Y-shaped protein, roughly 150,000 daltons — about three hundred times the mass of a small-molecule drug. Each arm ends in a binding region shaped, over many generations of the immune system or in the lab, to grip one specific target with very high affinity. Because the binding surface is large and contoured, antibodies achieve a selectivity small molecules struggle to match: they can tell apart two proteins that differ by only a few amino acids.

That precision pairs with a long half-life. Antibodies are recycled by a salvage receptor (FcRn) that rescues them from degradation, so a single dose can persist for weeks — which is why many antibody drugs are given every few weeks rather than daily. The flip side: if something goes wrong, you cannot quickly wash the drug out.

The hard limits: outside only, and injected

An antibody is far too large and too polar to cross a cell membrane. So its targets must be reachable from outside: proteins floating in the blood, or receptors and antigens displayed on the cell surface. The entire enormous catalogue of intracellular proteins is off-limits to a plain antibody. It also cannot survive the gut, so it is given by injection or infusion, not as a pill.

Engineering: turning the antibody into a platform

Once you can make an antibody to order, you can rebuild it. A bispecific antibody grabs two different targets at once — for instance, one arm holding a tumour cell while the other drags in a killer T cell. An antibody–drug conjugate (ADC) bolts a potent cytotoxic payload onto the antibody, using its precision as a delivery address: the antibody finds the tumour, gets pulled inside, and only then releases the toxin.

The unglamorous hero of an ADC is the linker — the chemistry that joins payload to antibody. It must stay locked in the bloodstream so the toxin doesn't leak everywhere, then cleave cleanly inside the target cell. Get the linker wrong and a beautiful targeting antibody becomes a poison delivered to the wrong place.